Sponsors

This page lists the sponsors of the 4^th World Congress on Electroporation.

Platinum Sponsors

Farapulse, Inc. — farapulse.com

FARAPULSE Inc. is a privately-held company developing a pulsed field ablation (PFA) system for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias. This PFA system – comprising a sheath, generator and catheters – is intended to ablate heart tissue via the creation of a therapeutic electric field instead of using thermal energy sources such as radiofrequency ablation or cryoablation. The FARAPULSE PFA System is an investigational device and not available for sale.

OncoSec, Inc. — oncosec.com

OncoSec is a late-stage biotechnology company developing immunotherapy cancer treatments using our plasmid DNA delivery platform. Through our proprietary technology, we are working to deliver safe and effective cancer treatments that can provide longterm benefits for patients.

IGEA, S.p.A. — www.igeamedical.com

IGEA studies the clinical application of physical stimuli to biological systems. Our mission is to improve patients’ quality of life by developing and producing innovative, effective and safe therapeutic systems for clinical practice. IGEA is the world leading company for Electrochemotherapy, a minimally invasive treatment combining a low dose of a chemotherapy drug and electrical pulses (electroporation) applied directly to the cancer cells using specific multiple or individual electrodes. Cliniporator® and Cliniporator® VITAE are the most advanced electroporation technologies for the treatment of tumor nodules located to the skin, subcutaneous tissue, parenchyma and bone.

Medtronic, Inc. — medtronic.com

Making healthcare better is our priority and we believe technology can play an even greater role in improving people’s lives. In addition to alleviating pain, restoring health, extending lives, we work in partnership with others to create seamless, more efficient care. Learn how we’re taking healthcare Further, Together at Medtronic.com.

Gold Sponsors

AngioDynamics, Inc. — www.angiodynamics.com

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, vascular interventions & therapies, & oncology. Diverse product lines include market-leading ablation systems, vascular access products, angiographic products & accessories drainage products, thrombolytic products & venous products. Learn more at angiodynamics.com.

Diversified Technologies, Inc. — www.divtecs.com

Diversified Technologies, Inc. (DTI), a privately held company headquartered in Bedford, Massachusetts, USA, is the developer, manufacturer, and marketer of the PowerMod™ line of solid-state power supplies, pulse modulators, power converters and related high voltage, high power equipment. Founded in 1987, DTI develops advanced technologies through a wide range of commercial and government contracts. DTI’s high voltage systems are used for defense and industrial applications including radar, power conversion, food sterilization, biomass oil extraction, and high-energy physics.

Elea Technology
(Elea Vertriebs- und Vermarktungsgesellschaft mbH) — elea-technology.de

With over 175 installed systems worldwide, Elea is the leading supplier of Pulsed Electric Field (PEF) systems to the food, beverage, and scientific sectors. PEF is an energy-efficient method to open cells of fresh fruit, vegetables, or other raw materials such as meat. This has the effect of extending shelf life or making more efficient use of the raw material for a better final product. The largest machines in the Elea PEF Advantage system range can process up to 60 tonnes of solids or 6000 litres of liquid per hour.

Pulse Biosciences, Inc. — www.pulsebiosciences.com

Pulse Biosciences is a novel bioelectric medicine company that has developed the CellFX™ Nano-Pulse Stimulation™ system which clears skin lesions by targeting the cell’s own self-destruct pathway. The CellFX applies ultra-short electric pulses for a few seconds to initiate the target cell’s own fail-safe mechanism of regulated cell death without disrupting acellular tissue. This revolutionary approach eliminates the lesion in a scarless, painless manner that does not heat the tissue more than a few degrees. The CellFX™ has received clearance from the FDA for the treatment of benign skin lesions in the USA, along with receiving a CE mark in the European Union and approval from Health Canada.

Scandinova Systems AB — www.scandinovasystems.com

ScandiNova (www.scandinovasystems.com) is by its break-through technology a world leader in development and production of Pulsed Power Systems with high power levels. The product range covers pulse modulators / generators and RF units. The solutions have a key function in radiotherapy, scientific and industrial applications such as food processing (PEF), with customers such as CERN, Varian Medical Systems and Heat and Control. ScandiNova was founded in 2001 and has its head-office in Uppsala, Sweden with 100 employees.